NCT00140192View on ClinicalTrials.gov

Creatine Treatment in Psychiatric Disorders

PHASE3CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

September 30, 2004

Primary Completion Date

March 31, 2006

Study Completion Date

March 31, 2006

Conditions
Schizophrenia
Interventions
DRUG

creatine

Trial Locations (1)

Unknown

Beersheva Mental Health Center, Beersheva

All Listed Sponsors
collaborator

National Alliance for Research on Schizophrenia and Depression

OTHER

lead

Beersheva Mental Health Center

OTHER_GOV

NCT00140192 - Creatine Treatment in Psychiatric Disorders | Biotech Hunter | Biotech Hunter